世界のヒトミルクオリゴ糖 (HMO) 市場：動向および予測（2019年～2025年）
Global Human Milk Oligosaccharides Market - Trends & Forecast, 2019-2025
|世界のヒトミルクオリゴ糖 (HMO) 市場：動向および予測（2019年～2025年）|
発行: Market Research Future
ページ情報: 英文 88 Pages
世界のヒトミルクオリゴ糖 (HMO) 市場は、2018年に1億1,003万米ドルとなりました。同市場は、2025年までの間に27.06％のCAGRで成長する見通しです。
当レポートは世界のヒトミルクオリゴ糖 (HMO) 市場について調査しており、市場機会や課題、成長および阻害要因、タイプ・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。
Human Milk Oligosaccharides Market Research Report - Global Forecast till 2025
Global Human Milk Oligosaccharides Market Information: Information by Type (Neutral and Acidic), Application (Food Industry and Laboratory Research) and Region (North America, Europe, China and Japan) - Forecast till 2025
After fats and carbohydrates, the third most abundant ingredient in human breast milk is Human milk oligosaccharides (HMOs). They are sugar molecules and found in high concentrations in breast milk.
To the increasing application of HMOs in functional foods and rising demand in infant formula leads to the growth "The global human milk oligosaccharides market". However, the high cost of production is hindering the growth of the global human milk oligosaccharides market.
From past few years people has become health conscious. This has resulted in thorough changes in the lifestyle and diet. People are driven towards the functional foods, such as dietary supplements and probiotics, globally that's resulted in the rise in demand of the same.
HMOs in functional food products and beverages remove injurious bacteria such as salmonella and campylobacter and help to generate the growth of good bacteria.
The use of HMOs in adult nutrition such as functional foods and supplements is increasing due to their benefits such as refining gut microbiota and enhancing the immune system. These factors are likely to drive the growth of the market during the forecast period. The Global Human Milk Oligosaccharides Market is Expected to Register a CAGR of 27.06% During the Assessment Period with a Market Value of USD 110.03 Million in 2018. In the year 2018 due to the high consumption of infant formula in the region North America accounted for the largest share of the global human milk oligosaccharides market. In the year 2018, the second-largest revenue share of the global market was of Europe. As per the 2017 report published by UNICEF, the UK has one of the lowest rates of breastfeeding in the world, with just 34% of babies receiving breast milk at six months of age.Therefore, the key factors inducing the progress of the European market are the low rates of breastfeeding and increasing EU consents for newly launched HMO-based products. due to the decline in infant population; the Japanese market accounted for a share of 3.26% in 2018 and hence, it held the smallest share of the global human milk oligosaccharides market
Global Human Milk Oligosaccharides Market is divided by Type, by application and by region. On the basis of type it is divided into Acidic and Neutral(projected to reach USD 563.13 Million by 2025). On the basis of application it is divided into Food Industry and Laboratory Research. On the basis of region, it is divided in the regions like North America, Europe, China and Japan.
The global human milk oligosaccharides market has been divided, based on region, into North America, Europe, China, and Japan.
BASF SE (Germany), Dextra Laboratories Limited (UK), DuPont Nutrition & Health (Denmark), Glycom (Denmark), Glycosyn LLC (US), Jennewein Biotechnologie GmbH (Germany), Medolac Laboratories (US), Nestle Health Science (Switzerland) and ZuChem (US), Abbott (US), Elicityl S.A. (France), Inbiose NV (Belgium) are the major players in the Global Human Milk Oligosaccharides Market